Clinical Trial Update: A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers [Phase 2]

View source ↗

Summary

A Phase 2, open-label, randomized, parallel-group, placebo-controlled, single-center trial in healthy volunteers evaluated the antimicrobial efficacy and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Infection

Drugs mentioned

• DCN01
• Unisol

Snippet

Sponsor: Deacon Biosciences, Inc. | Conditions: Ocular Infection | Phase 2 | Status: COMPLETED